Legend Biotech Management
Management criteria checks 1/4
Legend Biotech's CEO is Ying Huang, appointed in Sep 2020, has a tenure of 3.67 years. directly owns 0.035% of the company’s shares, worth $2.95M. The average tenure of the management team and the board of directors is 2 years and 2.9 years respectively.
Key information
Ying Huang
Chief executive officer
n/a
Total compensation
| CEO salary percentage | n/a |
| CEO tenure | 3.7yrs |
| CEO ownership | 0.04% |
| Management average tenure | 2yrs |
| Board average tenure | 2.9yrs |
Recent management updates
Recent updates
Legend Biotech: AdCom Documents Shed Light On Carvykti's Problems (Downgrade)
Mar 15Is Legend Biotech (NASDAQ:LEGN) A Risky Investment?
Mar 06
Legend Biotech: Solid Traction With Carvykti Rollout
Jan 29Legend Biotech Corporation's (NASDAQ:LEGN) Share Price Not Quite Adding Up
Jan 16Is Legend Biotech (NASDAQ:LEGN) A Risky Investment?
Nov 09Is Legend Biotech (NASDAQ:LEGN) Weighed On By Its Debt Load?
Apr 12An Intrinsic Calculation For Legend Biotech Corporation (NASDAQ:LEGN) Suggests It's 44% Undervalued
Dec 14Legend Biotech wins approval of Carvykti for multiple myeloma in Japan
Sep 27Legend Biotech stock slides on proposed ADS offering
Jul 25Legend Biotech ends Phase 1 trial for lymphoma candidate
Jul 07News Flash: Analysts Just Made A Notable Upgrade To Their Legend Biotech Corporation (NASDAQ:LEGN) Forecasts
Jun 05Legend Biotech (NASDAQ:LEGN) Has Debt But No Earnings; Should You Worry?
May 14Here's What Analysts Are Forecasting For Legend Biotech Corporation (NASDAQ:LEGN) After Its Full-Year Results
Mar 22Legend Biotech: Carvykti Approval Makes For A Buy Opportunity
Mar 04Legend Biotech Corporation (NASDAQ:LEGN) Analysts Are More Bearish Than They Used To Be
Mar 03Is Legend Biotech (NASDAQ:LEGN) Weighed On By Its Debt Load?
Dec 30Calculating The Intrinsic Value Of Legend Biotech Corporation (NASDAQ:LEGN)
Nov 22Is Legend Biotech (NASDAQ:LEGN) Using Debt Sensibly?
Aug 26Analysts Have Just Cut Their Legend Biotech Corporation (NASDAQ:LEGN) Revenue Estimates By 18%
Jun 11CEO
Ying Huang (50 yo)
3.7yrs
Tenure
Dr. Ying Huang, Ph D., had been Chief Financial Officer of Legend Biotech Corporation since July 2019 until May 09, 2022 and was its Interim Chief Executive Officer since September 21, 2020 until November...
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| CEO & Director | 3.7yrs | no data | 0.035% $ 3.0m | |
| Chief Financial Officer | 2yrs | no data | 0.0031% $ 258.2k | |
| Vice President of Global Operations | less than a year | no data | no data | |
| Chief Scientific Officer & Head of Business Development | no data | no data | no data | |
| Senior Manager of Investor Relations | no data | no data | no data | |
| General Counsel | less than a year | no data | no data | |
| Executive Director of Strategic Marketing & Corporate Communications | no data | no data | no data | |
| VP & Global Head of Human Resources | 1.1yrs | no data | no data | |
| Senior Vice President of Global Regulatory Affairs | 2.3yrs | no data | no data | |
| Senior Vice President of Commercial Development | 2.3yrs | no data | no data | |
| Senior Vice President of Global Quality | 2.3yrs | no data | no data | |
| Chief Medical Officer | 1.1yrs | no data | no data |
2.0yrs
Average Tenure
50yo
Average Age
Experienced Management: LEGN's management team is considered experienced (2 years average tenure).
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| CEO & Director | 2.4yrs | no data | 0.035% $ 3.0m | |
| Member of Strategic Advisory Board | 1.1yrs | no data | no data | |
| Non-Independent Director | 3.5yrs | no data | no data | |
| Independent Director | 4yrs | no data | 0.011% $ 881.5k | |
| Independent Director | 4yrs | no data | 0.0051% $ 423.6k | |
| Independent Director | 1.8yrs | no data | 0.0011% $ 93.6k | |
| Independent Chairman | 1.8yrs | no data | 0% $ 0 | |
| Director | 9yrs | no data | 0% $ 0 | |
| Member of Strategic Advisory Board | 1.1yrs | no data | no data | |
| Independent Director | 4yrs | no data | 0.0010% $ 86.1k | |
| Independent Director | 3.4yrs | no data | 0.0070% $ 581.5k | |
| Independent Director | 1.8yrs | no data | 0.0019% $ 159.6k |
2.9yrs
Average Tenure
61yo
Average Age
Experienced Board: LEGN's board of directors are not considered experienced ( 2.9 years average tenure), which suggests a new board.